# Dessight Biomedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dessight-biomedical

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.dessight.cn
- Total disclosed funding: $14M
- Latest round: Series A (Jan 19, 2026)
- Investors on record: 5

## About

Based in Hangzhou, China and founded in 2021, Hangzhou Dessight Biomedical Co., Ltd., Dessight Biomedical, is a medical equipment company that focuses on surgery robots for ophthalmology. Its founder team is from robotic and artificial intelligence labs in Germany, and German medical corporations. It has an equipment and disposable R&D center, and production bases. The company also established cooperation relationships with Zhejiang University and the Technical University of Munich. In January 2026, Dessight Biomedical closed Series A2 funding led by returning investor Fortune Capital, with participation from other returning investor Panlin Capital.
The company provides microscopy surgery robots for ophthalmology. The robots reached 3um movement precision. It also provides ophthalmic surgical assist systems, microsurgical assist systems, and related medical devices. The products can be used in the fields of ear, nose, and throat, lymphatic surgery, neurosurgery, and plastic surgery.
The company generates revenue by developing robots for eye surgery and other related products.
The Series A2 funding raised in January 2026 will be used to advance product development, clinical trials, and market expansion, further solidifying its technological advantage in the field of intelligent ophthalmic surgery.

## Funding rounds

- Series A, Jan 19, 2026 — Fortune Capital, Panlin Capital
- Series A, Jun 16, 2025, $14M — Hangzhou High-Tech Investment, Panlin Capital, Jinyuan Kuntong Equity Investment Management, Hangzhou Uptown Capital Private Equity Fund Management Co., Ltd.
- Series A, Jan 4, 2024 — Fortune Capital

## Investors

- Fortune Capital — Series A
- Hangzhou High-Tech Investment (https://capitalatlas.ai/funds/hangzhou-high-tech-investment) — Series A
- Panlin Capital (https://capitalatlas.ai/funds/panlin-capital) — Series A
- Jinyuan Kuntong Equity Investment Management (https://capitalatlas.ai/funds/jinyuan-kuntong-equity-investment-management) — Series A
- Hangzhou Uptown Capital Private Equity Fund Management Co., Ltd. (https://capitalatlas.ai/funds/hangzhou-uptown-capital-private-equity-fund-management-co-lt) — Series A